Galectin Therapeutics (GALT) Change in Cash (2010 - 2026)
Galectin Therapeutics' quarterly Change in Cash came in at -$3.6 million in Q1 2026, up 53.06% year-on-year from -$2.4 million in Q1 2025, and down 158.26% quarter-over-quarter from $6.2 million in Q4 2025.
Galectin Therapeutics has reported Change in Cash for 17 years, with the latest figure at -$3.6 million in Q1 2026.
- For the quarter ending Q1 2026, Change in Cash rose 53.06% year-over-year to -$3.6 million; the trailing twelve-month figure through Mar 2026 stood at $6.7 million (up 141.43% YoY), and the FY2025 full-year result was $2.6 million, up 124.67% from the prior year.
- Change in Cash for Q1 2026 stood at -$3.6 million, down from $6.2 million in the prior quarter.
- The five-year high for Change in Cash was $6.3 million in Q2 2025, with the low at -$11.9 million in Q4 2024.
- Average Change in Cash over 5 years is -$1.5 million, with a median of -$793000.0 recorded in 2023.
- Peak annual rise in Change in Cash reached 1123.35% in 2024, while the deepest fall reached 325.37% in 2024.
- Tracing GALT's Change in Cash over 5 years: stood at $2.8 million in 2022, then soared by 91.89% to $5.3 million in 2023, then plunged by 325.37% to -$11.9 million in 2024, then surged by 151.88% to $6.2 million in 2025, then slumped by 158.26% to -$3.6 million in 2026.
- The last three Change in Cash figures came in at -$3.6 million (Q1 2026), $6.2 million (Q4 2025), and -$2.2 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | 2.44 Mn |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 623.00 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | -2.44 Mn |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 417.10 Mn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | -153.10 Mn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 53.61 Mn |
| 10 | Galectin Therapeutics | 165.77 Mn | 151.67 Mn | - | -3.61 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3.61 Mn |
| Dec 31, 2025 | 6.20 Mn |
| Sep 30, 2025 | -2.25 Mn |
| Jun 30, 2025 | 6.34 Mn |
| Mar 31, 2025 | -7.69 Mn |
| Dec 31, 2024 | -11.94 Mn |
| Sep 30, 2024 | 1.46 Mn |
| Jun 30, 2024 | 2.04 Mn |
| Mar 31, 2024 | -2.11 Mn |
| Dec 31, 2023 | 5.30 Mn |
| Sep 30, 2023 | 2.40 Mn |
| Jun 30, 2023 | 167,000.00 |
| Mar 31, 2023 | -793,000.00 |
| Dec 31, 2022 | 2.76 Mn |
| Sep 30, 2022 | -8.35 Mn |
| Jun 30, 2022 | -7.43 Mn |
| Mar 31, 2022 | -8.04 Mn |
| Dec 31, 2021 | 3.05 Mn |
| Sep 30, 2021 | 5.00 Mn |
| Jun 30, 2021 | 10.84 Mn |
| Mar 31, 2021 | -6.38 Mn |
| Dec 31, 2020 | -5.41 Mn |
| Sep 30, 2020 | -8.21 Mn |
| Jun 30, 2020 | -2.56 Mn |
| Mar 31, 2020 | -4.15 Mn |
| Dec 31, 2019 | -2.86 Mn |
| Sep 30, 2019 | -1.71 Mn |
| Jun 30, 2019 | 45.07 Mn |
| Mar 31, 2019 | -1.28 Mn |
| Dec 31, 2018 | -1.88 Mn |
| Sep 30, 2018 | -361,000.00 |
| Jun 30, 2018 | 6.51 Mn |
| Mar 31, 2018 | 935,000.00 |
| Dec 31, 2017 | -3.91 Mn |
| Sep 30, 2017 | -2.17 Mn |
| Jun 30, 2017 | -4.52 Mn |
| Mar 31, 2017 | -1.72 Mn |
| Dec 31, 2016 | -697,000.00 |
| Sep 30, 2016 | -1.94 Mn |
| Jun 30, 2016 | -4.35 Mn |
| Mar 31, 2016 | -3.49 Mn |
| Dec 31, 2015 | 4.53 Mn |
| Sep 30, 2015 | -5.04 Mn |
| Jun 30, 2015 | -2.99 Mn |
| Mar 31, 2015 | 221,000.00 |
| Dec 31, 2014 | 400,000.00 |
| Sep 30, 2014 | -3.22 Mn |
| Jun 30, 2014 | -2.17 Mn |
| Mar 31, 2014 | 26.11 Mn |
| Dec 31, 2013 | 774,000.00 |
| Sep 30, 2013 | 4.62 Mn |
| Jun 30, 2013 | -1.92 Mn |
| Mar 31, 2013 | -2.35 Mn |
| Dec 31, 2012 | -1.70 Mn |
| Sep 30, 2012 | -2.07 Mn |
| Jun 30, 2012 | -2.18 Mn |
| Mar 31, 2012 | 8.92 Mn |
| Dec 31, 2011 | -1.55 Mn |
| Sep 30, 2011 | -40,000.00 |
| Jun 30, 2011 | 1.04 Mn |
| Mar 31, 2011 | 1.06 Mn |
| Dec 31, 2010 | 3.08 Mn |
| Sep 30, 2010 | -49,000.00 |